GrantSet

Grant opportunity · PAR-24-297

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Applications close526 days leftJan 7, 2028
AgencyNational Institutes of Health
CategoryDiscretionary
Assistance listing93.279
OpensSep 17, 2024
ClosesJan 7, 2028
Award floor
Award ceiling$150,000
Expected awardsNot stated

Who can apply (as listed)

  • Independent school districts
  • Small businesses
  • Native American tribal governments (federally recognized)
  • State governments
  • County governments
  • City or township governments
  • Nonprofits with 501(c)(3) status (other than institutions of higher education)
  • Special district governments
  • Public and state-controlled institutions of higher education
  • For-profit organizations (other than small businesses)
  • Others (see the opportunity text)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than federally recognized governments)
  • Private institutions of higher education
  • Nonprofits without 501(c)(3) status (other than institutions of higher education)
From the listing

This Notice of Funding Opportunity Announcement (NOFO) is designed to encourage and facilitate the entry of investigators to the area of brain imaging research. This NOFO will support both newly independent investigators and established investigators who are seeking to develop and adopt neuroimaging tools and methodologies in their research programs and conduct small "proof-of-concept" studies relevant to substance use disorders and addiction. This NOFO is intended to support Small Research Grant (R03) projects that can be carried out in a short period of time with limited resources.

Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.

GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.